Genomic variant representation in a Chlamydia population is dynamic and adaptive with dependence on in vitro and in vivo passage

Pathogens and Disease

Volumn 73, Issue 1, 2015, Pages

  Jasper, Deana K ^a   Sigar, Ira M ^a   Schripsema, Justin H ^a   Sainvil, Carlyn K ^a   Smith, Christopher L ^a   Yeruva, Laxmi ^b   Rank, Roger G ^b   Murthy, Ashlesh K ^a   Widder, Jared R ^a   Ramsey, Kyle H ^a  

^a MIDWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Allele; Chlamydia; Genome; Genotype; Host; Polymorphism

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHLAMYDIA MURIDARUM; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA POLYMORPHISM; EXPERIMENTAL MOUSE; GENETIC VARIABILITY; GENOTYPE; GROWTH RATE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UROGENITAL SYSTEM; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; CHLAMYDIASIS; CLASSIFICATION; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPING TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGY; UROGENITAL TRACT DISEASE;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FEMALE; FEMALE UROGENITAL DISEASES; GENOTYPE; GENOTYPING TECHNIQUES; MICE, INBRED BALB C; MICE, INBRED C3H; POLYMORPHISM, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84937794929     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1093/femspd/ftu003     Document Type: Article

References (44)

1. Batteiger BE. Chlamydia infection and epidemiology. In: Tan M, Bavoil PM ( eds). Intracellular Pathogens I: Chlamydiales. Washington, DC, USA: ASM Press 2012, 1-26.
2. Binet R, Bowlin AK, Maurelli AT, et al. Impact of azithromycin resistancemutations on the virulence and fitness of Chlamydia caviae in guinea pigs. Antimicrob Agents Ch 2010;54:1094-101.
3. Borges V, Ferreira R, Nunes A, et al. Effect of long-term laboratory propagation on Chlamydia trachomatis genome dynamics. Infect Genet Evol 2013;17:23-32.
4. Clarke IN. Update on the genetics and genomics of Chlamydia trachomatis. In: Schachter J, Byrne GI, Chernesky MA, et al. (eds). Chlamydial Infections: Proceedings of the 13th International Symposium on Human Chlamydial Infections. San Francisco, CA, USA: University of California 2014, 67-76.
5. Conrad T, Chen C, Zhong G. Mutation curator (MUTACUR): a novel tool for studying chlamydial mutation dynamics, population distribution, and functional consequence. In: Schachter J, Byrne GI, Chernesky MA, et al. ( eds). Chlamydial Infections: Proceedings of the 13th International Symposium on Human Chlamydial Infections. San Francisco, CA, USA: University of California 2014, 109-12.
6. Cotter TW, Meng Q, Shen Z, et al. Protective efficacy of major outer membrane protein specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun 1996;63:4704-14.
7. Cotter TW, Miranpuri GS, Ramsey KH, et al. Reactivation of chlamydial genital tract infection in mice. Infect Immun 1997;65:2067-73.
8. De La Maza LM, Pal S, Khamesipour A, et al. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 1994;62:2094-7.
9. DeMars R, Weinfurter J, Guex E, et al. Lateral gene transfer in vitro in the intracellular pathogen Chlamydia trachomatis. J Bacteriol 2007;189:991-1003.
10. Fechtner T, Stallmann S, Moelleken K, et al. Characterization of the interaction between the chlamydial adhesin OmcB and the human host cell. J Bacteriol 2013;195:5323-33.
11. Geisler WM, Tang J, Wang C, et al. Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents. J Infect Dis 2004;190:1723-9.
12. Gieffers J, Durling L, Ouellette SP, et al. Genotypic differences in the Chlamydia pneumoniae tyrP locus related to vascular tropism and pathogenicity. J Infect Dis 2003;188:1085-93.
13. Gomes JP, Bruno WJ, Nunes A, et al. Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots. Genome Res 2007;17:50-60.
14. Gomes JP, Nunes A, Bruno WJ, et al. Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism. J Bacteriol 2006;188:275-86.
15. Gordon FB, Freeman G, Clampit JM. A pneumonia-producing filtrable agent fromstockmice. P Soc Exp Biol Med 1938;39:450-3.
16. Imtiaz MT, Distelhorst JT, Schripsema JH, et al. A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice. Microbes Infect 2007;9: 1561-6.
17. Jeffrey BM, Maurelli AT, Rockey DD. Chlamydial genetics: decades of effort, very recent successes. In: Tan M, Bavoil PM. ( eds). Intracellular Pathogens 1: Chlamydiales. Washington, DC: ASM Press 2012, 334-51.
18. Kaltenboeck B. Recent advances in the knowledge of animal chlamydial infections. In: Chernesky MA, Caldwell HD, Christiansen G, et al. ( eds). Proceedings of the 11th International Symposium on Human Chlamydial Infections. San Francisco, CA, USA: University of California 2006, 399-408.
19. Kari L, Whitmire WM, Carlson JH, et al. Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations. J Infect Dis 2008;197:449-56.
20. Lee HY, Schripsema JH, Sigar IM, et al. A link between neutrophils and chronic disease manifestations of Chlamydia muridarum urogenital infection of mice. FEMS Immunol Med Mic 2010a;59:108-16.
21. Lee HY, Schripsema JH, Sigar IM, et al. A role for CXC chemokine receptor-2 in the pathogenesis of urogenital Chlamydia muridarum infection in mice. FEMS Immunol Med Mic 2010b;60:49-56.
22. Miyairi I, Laxton JD, Wang X, et al. Chlamydia psittaci genetic variants differ in virulence by modulation of host immunity. J Infect Dis 2011;204:654-63.
23. Miyairi I, Tatireddigari VR, Mahdi OS, et al. The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection. J Immunol 2007;179:1814-24.
24. Natividad A, Cooke G, Holland MJ, et al. A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection. BMC Med Genet 2006;7:40.
25. Natividad A, Hanchard N, Holland MJ, et al. Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians. Genes Immun 2007;8:288-95.
26. Natividad A, Holland MJ, Rockett KA, et al. Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation. Hum Mol Genet 2008;17:323-9.
27. Natividad A, Wilson J, Koch O, et al. Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun 2005;6:332-40.
28. Nigg C. An unidentified virus which produces pneumonia and systemic infection in mice. Science 1942;95:49-50.
29. O'Connell CM, Nicks KM. A plasmid-cured Chlamydia muridarum strain displays altered plaque morphology and reduced infectivity in cell culture. Microbiol 2006;152:1601-7.
30. Ramsey KH, Cotter TW, Salyer RD, et al. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection. Infect Immun 1999;67:3019-25.
31. Ramsey KH, DeWolfe JL, Salyer RD. Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis. Infect Immun 2000;68:7186-9.
32. Ramsey KH, Sigar IM, Schripsema JH, et al. Strain and virulence diversity in the mouse pathogen Chlamydia muridarum. Infect Immun 2009;77:3284-93.
33. Read TD, Brunham RC, Shen C, et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 2000;28:1397-406.
34. Schachter J, Meyer KF. Lymphogranuloma venereum. II. Characterization of some recently isolated strains. J Bacteriol 1969;99:636-8.
35. Seth-Smith HM, Harris SR, Scott P, et al. Generating whole bacterial genome sequences of low-abundance species from complex samples with IMS-MDA. Nat Protoc 2013a;8:2404-12.
36. Seth-Smith HM, Harris SR, Skilton RJ, et al. Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res 2013b;23:855-66.
37. Shah AA, Schripsema JH, Imtiaz MT, et al. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis 2005;32:49-56.
38. Sturdevant GL, Kari L, Gardner DJ, et al. Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract. Infect Immun 2010;78:3660-8.
39. Su H, Messer R, Whitmire W, et al. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med 1998;188:809-18.
40. Su Y, Wang X, Jones W, et al. Host genetics and upper genital tract disease in Chlamydia muridarum infected mice: a forward genetic approach with translational implications. In: Schachter J, Byrne GI, Chernesky MA, et al. ( eds). Chlamydial Infections: Proceedings of the 13th International Symposium on Human Chlamydial Infections. San Francisco, CA, USA: University of California 2014, 261-4.
41. Sullivan J, Fraser L, Darville TL, Chlamydia muridarum contains multiple variants exhibiting different phenoytpic properties. In: Schachter J, Byrne GI, Chernesky MA, et al. ( eds). Chlamydial Infections: Proceedings of the 13th International Symposium on Human Chlamydial Infections. San Francisco, CA, USA: University of California 2014a, 93-6.
42. Sullivan J, Nagarajan U, Frazer L, A hypervirulent variant of C. muridarum resists clearance by interferon-gamma responsive mechanisms. In: Schachter J, Byrne GI, Chernesky MA, et al. ( eds). Chlamydial Infections: Proceedings of the 13th International Symposium on Human Chlamydial Infections. San Francisco, CA, USA: University of California 2014b, 117-20.
43. Wang C, Tang J, Geisler WM, et al. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. J Infect Dis 2005;191:1084-92.
44. Yeruva L, Myers GS, Spencer N, et al. Early microRNA expression profile as a prognostic biomarker for the development of pelvic inflammatory disease in a mousemodel of chlamydial genital infection. MBio 2014;5:e01241-14.